Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Razer: Aggressive Discounting, There Could Be Trouble Ahead

Razer Pre-IPO Review - For Gamers. By Gamers. But, Is It for Investors?

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

<p>Razer, a global gaming and lifestyle brand, launched its book building this week to raise up to USD627m. <a href="https://www.smartkarma.com/profiles/673" target="_blank" data-smartkarma-citation="accounts:673">Toh Zhen Zhou</a> covered the fundamentals of the name in his earlier insight <a href="https://www.smartkarma.com/insights/razer-pre-ipo-review-for-gamers-by-gamers-but-is-it-for-investors" target="_blank">here</a>. In this insight, we will dig further into the company's financial performance, discuss its valuation and score the deal in our ECM Framework. </p><div>
<h2>Deal and framework score overview</h2>
<p>The embed below is from our IPO tool, which has been designed to provide you with timely information on all IPO related events (Book…</p>
</div>

Razer, a global gaming and lifestyle brand, launched its book building this week to raise up to USD627m. Toh Zhen Zhou covered the fundamentals of the name in his earlier insight here. In this insight, we will dig further into the company's financial performance, discuss its valuation and score the deal in our ECM Framework. 
Deal and framework score overview
The embed below is from our IPO tool, which has been designed to provide you with timely information on all IPO related events (Book…


Razer IPO: Premium Valuation for A Niche Market?

Razer Inc

Razer IPO: Premium Valuation for A Niche Market?